LIPOSTABIL

A. Nattermann & Cie GmbH

Application Filed: 2003-07-23

Trademark Application Details

Status

710

Dead/Cancelled

CANCELLED - SECTION 8

Research	OneLook Acronym Finder
Serial Number	78277602
Registration Number	2912914
Mark Drawing Code	1000: Typeset: Word(s)/letter(s)/number(s)
Cancellation Code	2
Domestic Representative	Margaret H. Bitler
Attorney Name	Margaret H. Bitler
Law Office Assigned	L20
Employee Name	OSBORNE, STANLEY I

Timeline

2003-07-23	Application Filed
2004-09-28	Published for Opposition
2004-12-21	Location: PUBLICATION AND ISSUE SECTION
2004-12-21	Trademark Registered
2011-07-22	Cancelled
2011-07-22	Status: Dead/Cancelled
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	A. Nattermann & Cie GmbH
Address	Nattermannnallee 1 Koln DE D-50829
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Susan Upton Douglass
Fross Zelnick Lehrman & Zissu, P.C.
866 United Nations Plaza
New York NY 10017

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	44
U.S. Codes:	100,101

Type Code	Type
GS0051	pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use in the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respirattory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use n the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; and pharmaceuticals for the treatment of weight and fat reduction issues

Type Code

Type

GS0051

pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use in the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respirattory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use n the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; and pharmaceuticals for the treatment of weight and fat reduction issues

Trademark Filing History

Description	Date	Event Coding
ASSIGNED TO EXAMINER	2003-12-15	1 DOCK D:Assigned to Examiner
NON-FINAL ACTION E-MAILED	2003-12-20	2 GNRT F:First Action
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2004-06-09	3 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2004-06-09	4 CRFA I:Incoming Correspondence
PAPER RECEIVED	2004-06-30	5 MAIL I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2004-06-30	6 CRFA I:Incoming Correspondence
AMENDMENT FROM APPLICANT ENTERED	2004-06-30	7 ACEC I:Incoming Correspondence
LETTER OF SUSPENSION E-MAILED	2004-07-13	8 GNSL S:
APPROVED FOR PUB - PRINCIPAL REGISTER	2004-07-19	9 CNSA O:Outgoing Correspondence
NOTICE OF PUBLICATION	2004-09-08	10 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2004-09-28	11 PUBO A:Allowance for Publication
REGISTERED-PRINCIPAL REGISTER	2004-12-21	12 R.PR A:Allowance for Publication
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2005-08-17	13 TCCA I:Incoming Correspondence
CANCELLED SEC. 8 (6-YR)	2011-07-22	14 C8.. O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.